Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 15, 2022--
The "Regenerative Medicine in Medical - Thematic Research" report has been added to ResearchAndMarkets.com's offering.
Based on the tracked sales of approved regenerative medicines, the report estimates that the market size in 2021 was $2.2 billion and will grow to over $23 billion by 2028 with a compound annual growth rate (CAGR) of 40.2%
Regenerative medicine is a burgeoning field in healthcare that holds the potential to fully cure patients of diseases, eliminate cancer, and fully repair and replace old and damaged tissue.
The three main branches of regenerative medicine are gene therapy, cell therapy, and tissue repair. As of 2021, there were 1,308 gene, cell, and tissue-based therapeutic developers worldwide.
Market players range from large dominant corporations, which can leverage their presence in relevant markets around the world, to small innovative start-ups, which continually develop novel technologies and expand regenerative medicine capabilities.
Scope
Reasons to Buy
Key Topics Covered:
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/leghgk
View source version on businesswire.com:https://www.businesswire.com/news/home/20220915005792/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/15/2022 09:48 AM/DISC: 09/15/2022 09:48 AM
http://www.businesswire.com/news/home/20220915005792/en